BiochemistrybioRxiv
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
F. Bertoglio, D. Meier, N. Langreder…·M. Hust
The paper identifies potent SARS-CoV-2 neutralizing antibodies from pre-pandemic human donors that bind the RBD-ACE2 interface, showing high neutralization efficacy in vitro.
DOI 10.1038/s41467-021-21609-2